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Bone-marrow-derived mesenchymal stem cells (BM-MSCs) were found to markedly increase atherosclerotic lesion size. The aim
of this paper was to investigate whether BM-MSCs contribute to vascular remodeling and calciﬁcation after balloon injury in
hyperlipidemic rats. Labeled BM-MSCs were found in the lesion of hyperlipidemic rats after balloon injury. Comparing injury
group, transferred BM-MSCs signiﬁcantly triggered vascular negative remodeling, characterized by the changes of remodeling
index(0.628±0.0293 versus0.544±0.0217), neointimalarea(0.078±0.015mm2 versus0.098±0.019mm2),PCNAindex(23.91±
6.59% versus 43.11±5.31%), and percentage of stenosis (18.20±1.09% versus 30.58±1.21%). Apparent vascular calciﬁcation was
detected in medial layers at 6 weeks after balloon angioplasty, which may be associated with upregulation of bone morphogenetic
protein-2 (BMP-2). Our data indicated that unselected BM-MSCs transfer may induce vascular remodeling and calciﬁcation after
balloon injury in hyperlipidemic rats.
1.Introduction
Cellulartherapyhasbeenanareaofintenseresearchoverfew
decades,whichiswidelyusedfortreatmentofcardiovascular
disease.Bone-marrow-derivedmesenchymalstemcells(BM-
MSCs) were isolated from adult bone marrow, along with
the ability for self-renewal and multilineage diﬀerentiation
into cardiomyocytes, smooth muscle cells, endothelium,
osteoblasts,andchondroblasts[1,2].Accumulatingevidence
from a growing body of animal studies demonstrated the
extensive capacity of MSCs to engraft, diﬀerentiate and
produce substantial functional recovery [3]. Transplantation
has been considered as a potential clinical strategy for the
treatment of ischemic heart diseases and heart failure.
Althoughagrowingbodyofevidencefromanimalexper-
iments and clinical trials indicated the beneﬁcial therapeutic
potential of MSCs in cardiovascular diseases, the safety of
MSCs transplantation is a critical problem that should be
kept in mind. The ﬁndings that MSCs transplantation could
result in tumor formation and alteration of electrophysio-
logic properties caused wide concerns [4, 5]. Furthermore,
unexpected severe intramyocardial calciﬁcation was elicited
by direct transplantation of unselected bone marrow cells
into acutely infarcted myocardium [6]. It has been demon-
strated that transfer of bone marrow and endothelial pro-
genitor cells accelerated atherosclerosis and inﬂuenced the
plaque stability [7]. Increasing evidence indicates a link
between MSCs therapy and pathogenesis of atherosclerosis
[8, 9].
Our previous studies demonstrated that oxidized LDL
synergistically promoted osteodiﬀerentiation of bone-mar-
row-derivedMSCsinresponsetoosteogenicinductor.Inthis
study, we investigated the eﬀects of transfer of unselected
BM-MSCs on vascular remodeling and calciﬁcation in the
hyperlipidemic rat.2 Journal of Biomedicine and Biotechnology
2. Method
2.1. Preparation of BM-MSCs. Unselected BM-MSCs were
extracted from male Sprague-Dawley (SD) rats (150∼200g)
femurs by ﬂushing the bone marrow cavities with Dulbecco’s
modiﬁed Eagle’s medium-low glucose (DMEM) and cul-
tured in DMEM supplemented with 10% fetal bovine serum
(FBS). After 24h, the medium was discarded to remove
hematopoieticstemcellsandnonadherentcells.Mediumwas
changed every 1∼2 days. Cells became almost conﬂuent after
8 days and were trypsinized with 0.25% trypsin containing
1mMEDT Afor3minat37 ◦C. All experiments were per-
formed on cells cultured for up to 3∼5 passages. BM-MSCs
were identiﬁed as CD90-positive and CD34-negative by ﬂow
cytometry.
2.2. Animals. All animal experiments were approved by the
Animal Care and Use Committee of Fudan University ac-
cording to the Guide for the Care and Use of Laboratory
Animals, published by the US National Institutes of Health
(NIH publication no. 85-23, revised 1996). Animals were fed
with high cholesterol diet containing 10% fat, 5% choles-
terol, 0.5% sodium cholate, and 0.2% propylthiouracil and
received vitamin D3 (600,000U/kgbody weight) for 1 week
before balloon denudation. Female SD rats were randomly
allocated to three groups: (1) rats without denudation were
fed with high cholesterol diet (Control, n = 8); (2) rats were
subjected to balloon denudation and fed with high choles-
terol diet (Injury group, n = 8); (3) rats were subjected
to balloon denudation and BM-MSCs transplantation plus
with high cholesterol diet (MSC group, n = 8). Rats
were anesthetized with ketamine (150mg/kg body weight
IP) and heparinized with 100U/kg heparin sodium before
procedures. A well-established rat model of aortic artery
balloon injury was used in this study. The abdominal aorta
wasisolatedandstrippedofadventitia.A6Fballooncatheter
was introduced through incision under the renal artery
bifurcation about 1cm and advanced into the thoracic aorta.
The balloon was inﬂated with saline and pulled back to the
abdominal aorta. After balloon denudation was performed
for 3 times, saline or BMSCs labeled by DAPI were injected
beforeremovalofthecatheter.Afterballoondenudation,rats
were fed with high cholesterol diet containing 10% fat, 5%
cholesterol, 0.5% sodium cholate, and 0.2% propylthiouracil
for 6 weeks after balloon denudation. In addition, rats
without denudation were fed with a normal diet to compare
with those with a high cholesterol diet.
2.3. Analyses of Plasma Lipid. After feeding, the rats were
fasted overnight and the samples were collected and cen-
trifuged at 3000rpm for 15min. The plasma lipid proﬁle was
determined by measuring the contents of total cholesterol
(TC) and low-density lipoprotein (LDL) by standard enzy-
matic procedures using reagent kits.
2.4. Histology. Paraﬃn sections of vascular tissue were
stained with hematoxylin-eosin for morphometric analysis
as previously described [10]. Histomorphometric parame-
ters, including luminal area (LA), internal elastic lamina area
(IELA), external elastic lamina area (EELA), and neointimal
area were deﬁned and determined using the software of Leica
QWin Plus as previously described [11]. The chronic varia-
tionoftheareasurroundedbytheexternalelasticlaminawas
evaluated by remodeling index compared with a reference
normal segment upstream from the lesion site, which was
calculated as a percentage as follows: EELA(lesion)/EELA
(reference). The percentage of stenosis was calculated as
(IELA−LA/IELA) × 100.
2.5. Von Kossa Stain. Von Kossa stain (Sigma-Aldrich, USA)
was performed to evaluate abnormal deposits of calcium
within vascular wall. Paraﬃn-ﬁxed tissue sections were incu-
bated with silver nitrate solution under a strong light. The
calcium was replaced with silver deposit, visualized as metal-
lic silver. Procedural details are described elsewhere [6].
2.6. Immunohistochemistry. Proliferative activity was deter-
mined in vascular tissue using analysis of proliferating cell
nuclear antigen (PCNA) expression deﬁned immunohisto-
chemically. In brief, tissue sections were quenched for endo-
genous peroxidase and antigen-retrieved in 0.01M citrate
buﬀer(pH6.0)for15mininamicrowaveovenat100◦C.The
sections were blocked with normal goat serum and then
incubated with mouse anti-PCNA antibody (Boster Com-
pany, China) overnight in a humid chamber at 4◦C. After
incubation with biotinylated goat anti-mouse IgG, sections
were visualized by using avidin-biotin horseradish peroxi-
dase visualization system. Sections were then counterstained
with haematoxylin. Images were recorded using Leica Qwin
Plus.
2.7. Immunoﬂuorescence Staining. Immunoﬂuorescence
staining was performed according to standard procedures.
Brieﬂy, vascular tissue sections were deparaﬃnized and
hydrated. After preincubation with normal goat serum,
sections were incubated with rabbit anti-BMP-2 antibody
(Boster Company, China) overnight in humid chamber at
4◦C followed by incubation with appropriate FITC-linked
secondary antibody. Images were captured by using Leica
Qwin Plus.
2.8. Statistical Analysis. Data were presented as means ±
SEM. Comparison was performed using one-way analysis of
variance (ANOVA) with Tukey test for post hoc analysis to
determine the diﬀerence among groups. P<0.05 was con-
sidered statistically signiﬁcant.
3. Result
3.1. Identiﬁcation of BM-MSCs Prepared for Transplantation.
For transplantation, unselected BM-MSCs were isolated
from bone marrow according to standard technique. A
few small, bright, round cells were present in the primary
culture, which gradually disappeared by the second genera-
tion or later (Figure 1(a)) .B M - M S C sw e r ec h a r a c t e r i z e da sJournal of Biomedicine and Biotechnology 3
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Figure 1: Identiﬁcation of BM-MSCs and the proﬁle of lipid level in cholesterol-rich fed rats. Phase contrast microscopy depicted that a few
small, bright, round cells were present in the primary culture (a). Phase contrast microscopy revealed that BM-MSCs were characterized as
a ﬁbroblast-like spindle-shaped morphology (b). Baseline of serum lipid content before received cholesterol-rich diet did not signiﬁcantly
diﬀer among three groups. Cholesterol-rich diet signiﬁcantly increased total serum cholesterol (c), and LDL (d) levels after angioplasty in
rats. The data were expressed as means ± SEM. n = 8p e rg r o u p . ∗P<0.05 versus normal diet group.
a ﬁbroblast-like spindle-shaped morphology (Figure 1(b)).
More than 95.69% of cells isolated from bone marrow were
positive for CD90, and negative for the early hematopoietic
marker CD34, indicating speciﬁc phenotype of BM-MSCs
markers.
3.2. The Proﬁle of Lipid Level in Rats with Cholesterol-Rich
Diet. Baseline of serum lipid content before received cho-
lesterol-rich diet did not signiﬁcantly diﬀer among three
groups. The addition of cholesterol to the diet signiﬁcantly
increasedtotalserumcholesterol,andLDLlevels.Procedures
of balloon angioplasty and BM-MSCs transplantation did
not aﬀect plasma lipid levels in this study (Figures 1(c) and
1(d)).
3.3. Eﬀect of BM-MSCs on Vascular Remodeling after Balloon
Angioplasty. To address vascular remodeling in vivo, histo-
logical analysis of vascular wall was assessed at 6 weeks after
balloon angioplasty. Ruptured internal elastic lamina was
present at the site of lesion, whereas splitting of the intima
was replaced with signiﬁcant neointimal formation after
balloon angioplasty in injury group and MSC group. Data
fromhistomorphometricparametersdepictedthatLA,IELA,
EELA, and remodeling index signiﬁcantly decreased after
balloon angioplasty (LA: 1.632 ± 0.043mm2 versus 1.335 ±
0.056mm2 versus 1.133 ± 0.074mm2; IELA: 1.632mm2 ±
0.043mm2 versus 1.414mm2 ± 0.073mm2 versus
1.185mm2 ± 0.086mm2; EELA: 2.403mm2 ± 0.067mm2
versus 1.509 ± 0.058mm2 versus1.308 ± 0.044; remodeling
index:1versus0.628±0.0293versus0.544 ± 0.0217;control
versus injury group versus MSC group, resp., P<0.05),
whereas signiﬁcant neointimal area and percentage of
stenosis were increased, compared with control (neointimal
area: 0 versus 0.078 ± 0.015mm2 versus 0.098 ± 0.019mm2,
P<0.05; percentage of stenosis: 0 versus 18.20 ± 1.09%
versus 30.58 ± 1.21%; control versus injury group versus
MSC group, resp., P<0.05). BM-MSCs transplantation
signiﬁcantly aggravated vascular negative remodeling when
compared with injury group, characterized by the decrease
of LA, IELA, EELA, and remodeling index and increased
neointimal area and percentage of stenosis (Figure 2).4 Journal of Biomedicine and Biotechnology
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Figure 2: Eﬀect of BM-MSCs on vascular remodeling after balloon angioplasty. Vascular tissues were stained with hematoxylin-eosin for
morphometric analysis. (a) Ruptured internal elastic lamina was present at the site of lesion, whereas splitting of the intima was replaced
with signiﬁcant neointimal formation after balloon angioplasty. (b) Histomorphometric parameters including LA, IELA, EELA, remodeling
index, neointimal area, and percentage of stenosis indicated vascular negative remodeling. The scale bar indicated 500µm (top row, 40x) and
100µm (bottom row, 400x), respectively. The data were expressed as means ± SEM. n = 8p e rg r o u p .∗P<0.05 versus control, #P<0.05
versus injury group.
3.4. Eﬀect of BM-MSCs on Neointimal Formation after
BalloonAngioplasty. Toinvestigatetheneointimalformation
in vivo, the PCNA index was evaluated. PCNA-stained
nuclei were detected in the neointimal and medial layers of
vascular wall at 6 weeks after vascular denudation (Figure 3).
Data demonstrated that BM-MSCs resulted in a signiﬁcant
increase in the neointimal area (0.078 ± 0.015mm2 versus
0.098 ± 0.019mm2, P<0.05), PCNA index (23.91 ± 6.59%
versus 43.11 ± 5.31%, P<0.05), and percentage of stenosis
(18.20 ± 1.09% versus 30.58 ± 1.21%, P<0.05) compared
with injury group.
3.5. Eﬀect of BM-MSCs on Vascular Calciﬁcation after Balloon
Angioplasty. To further characterize vascular calciﬁcation inJournal of Biomedicine and Biotechnology 5
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Figure 3: Eﬀect of BM-MSCs on neointimal formation after balloon angioplasty. (a) The PCNA expression was evaluated immunohisto-
chemically to investigate proliferative activity in vascular tissue. PCNA-stained nuclei were detected in the neointimal and medial layers of
vascular wall at 6 weeks after vascular denudation. (b) PCNA index was signiﬁcantly increased after BM-MSCs transplantation compared
with injury group. The data were expressed as means ± SEM. n = 8p e rg r o u p .∗P<0.05 versus control, #P<0.05 versus injury group.
lesions, von Kossa staining was performed. Typical of calciﬁ-
cation, revealing black metallic deposit, was obviously visu-
alized in medial layers in MSC group, compared control and
injury group (Figure 4(a)). In view of association between
bone morphogenetic protein-2 (BMP-2) and vascular cal-
ciﬁcation, the expression of BMP-2 was determined by
Immunoﬂuorescence staining. Results indicated that BMP-2
wasstrongly expressed in theneointimal and medial layersof
vascular wall (Figure 4(b)). These results indicated that BM-
MSCs-induced vascular calciﬁcation might be associated
with upregulation of BMP-2. To track the fate of BM-MSCs,
BM-MSCswereprelabeledbyDAPI.LabeledBM-MSCswere
homing in the intimal layers at 6 weeks after angioplasty,
indicating a role of BM-MSCs in the pathological changes
of vascular remodeling and calciﬁcation (Figure 4(c)).
4. Discussion
The salient ﬁndings from our current study indicated that
BM-MSCs transplantation triggered vascular remodeling
and calciﬁcation after balloon angioplasty in hyperlipidemic
rats. These results highlighted the potential importance of
complication caused by BM-MSCs which should keep in
mind in the therapeutic application.
Up to now, clinical trials for the treatment of ischemic
heart diseases and heart failure using bone marrow cells
were rapidly increased. Cell therapy has been regarded as a
potential clinical strategy for cardiovascular diseases. How-
ever,intensiveconcernsaboutdeleteriouseﬀectsreceivedsig-
niﬁcant attention, such as tumorigenicity, arrhythmia, and
unregulated diﬀerentiation. Studies from Losordo reported
fortheﬁrsttime thatsevereintramyocardialcalciﬁcationwas
detected after transplantation of unselected BM cells in acute
myocardial infarction [6]. The vascular remodeling and cal-
ciﬁcation were observed after balloon injury in hyperlipi-
demic rats. It is plausible that unselected BM-MSCs therapy
could lead to unexpected complication in coronary heart
disease patients with hyperlipidemia. Actually, patients with
coronary heart diseases complicated by hyperlipidemia were
clinically prevalent. Particularly, intracoronary delivery of
BM-MSCs was performed after successful percutaneous cor-
onary intervention in most of clinical trials. Thus, the gross
adverse eﬀect observed in the study could be clinically sig-
niﬁcant.
Increasing evidence indicated a link between bone-
marrow-derivedcellsandthepathogenesisofatherosclerosis.
Circulatingmyeloidcalcifyingcellswereidentiﬁedandfound
to contribute to ectopic vascular calciﬁcation in type 26 Journal of Biomedicine and Biotechnology
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Figure 4: Eﬀect of BM-MSCs on vascular calciﬁcation after balloon angioplasty and the fate of transferred BM-MSCs. (a) Von Kossa
staining was performed to detect vascular calciﬁcation in lesions black metallic deposit was obviously visualized in medial layers in MSC
group, compared control and injury group. (b) Immunoﬂuorescence staining was performed to determine the expression of BMP-2. Results
indicated that upregulated BMP-2 was strongly expressed in the neointimal and medial layers of vascular wall in MSC group, compared
Control and Injury groups. (c) Labeled BM-MSCs were homing in the intimal layers at 6 weeks after angioplasty. n = 8p e rg r o u p .
diabetes[12].Previousstudiesdemonstratedthattransferred
BM-MSCs were homing to the vascular lesion and markedly
increased atherosclerotic lesion size [7]. In this study, the
fate of transferred BM-MSCs were traced and found to
presentatalowdensityinthevascularsections.However,the
homing BM-MSCs may be underestimated, as quenching of
the DAPI cannot be completely excluded at 6 weeks after bal-
loon injury. It was indicated that BM-MSCs were potentially
involved in atherosclerotic calciﬁcation.
The mechanisms by which transferred BM-MSCs mod-
ulate vascular calciﬁcation remain unclear. Compelling evi-
dence suggested that vascular calciﬁcation was regulated
by bone calciﬁcation regulatory factors locally expressed in
bloodvessels[13–15].ParacrineBMP-2causedtheinduction
of osteoblast-like cells in intima and accelerated the ath-
erosclerotic calciﬁcation in vivo [16]. BMP-2 was found
to promote vascular calciﬁcation via increased phosphate
uptake and induction of osteogenic phenotype modulation
in smooth muscle cells [17]. Our observation that strongly
expression of BMP-2 was detected in the neointimal and
medial layers indicated a potential role of BMP-2 in the BM-
MSCs-induced calciﬁcation. Our data demonstrated that
ox-LDL was synergistically promoted osteodiﬀerentiation of
BM-MSCs co-cultured with vascular smooth muscle cells in
the presence of osteogenic inductor (unpublished data). It
was suggested that BM-MSCs together with balloon injury
and hyperlipidemia contribute to the formation of vascular
calciﬁcation.Journal of Biomedicine and Biotechnology 7
Taken together, we demonstrated an important role of
transferred BM-MSCs in vascular remodeling and calciﬁ-
cation. These ﬁndings call for caution in potential adverse
eﬀects with respect to BM-MSCs transfer in the future clini-
cal trials.
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